Artal Group S.A. Accelerate Diagnostics, Inc Call Options Transaction History

Artal Group S.A.

1 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2018 Aug 10, 2018	BUY	$19.02 - $24.95 $9.51 Million - $12.5 Million	500,000 New	500,000 $11.2 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $116M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.